Company
Horizon Therapeutics
Horizon Therapeutics has 3 drugs tracked on RxWires: 3 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| VIB7734 | Phase 1 | Acute Lung Injury |
| HZN-457 | Phase 1 | Healthy |
| Glycerol Phenylbutyrate 1100 MG/ML [Ravicti] | Phase 1 | STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder |
Latest
No recent events.
Follow Horizon Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.